Joel Greenblatt’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$457K Buy
+6,949
New +$541K ﹤0.01% 1608
2024
Q1
– Sell
-8,486
Closed -$343K – 1377
2023
Q4
$343K Buy
+8,486
New +$255K 0.01% 1099

Other funds holding BBIO

Joel Greenblatt's BBIO Position: Q3 2026 in Review

Joel Greenblatt opened a new position in BridgeBio Pharma (BBIO) in Q3 2026: 6,949 shares worth $457K. The stake represents ﹤0.01% of the portfolio and ranks #1608 among its holdings. This is a return to the name: Joel Greenblatt previously reported a position in BBIO as recently as Q4 2023.

Joel Greenblatt first reported a position in BBIO in Q4 2023 and has held it in 2 quarters since. 471 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.

  • Joel Greenblatt held 6,949 shares of BridgeBio Pharma worth $457K as of Q3 2026.
  • BridgeBio Pharma was a new Joel Greenblatt position in Q3 2026.
  • BridgeBio Pharma made up ﹤0.01% of Joel Greenblatt's portfolio in Q3 2026, its #1608 holding.
  • Joel Greenblatt first reported a position in BridgeBio Pharma in Q4 2023 and has held it in 2 quarters since.
  • 471 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.

Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.